N (%) or Median [IQR] | |
---|---|
Tocilizumab | 73 (86.9) |
Time from initiation to ICU admission (days) | 1 (− 1.5–3) |
Initiated before ICU admission | 53/73 (72.6) |
Number of injections | 2 [1–4] |
Corticosteroids a | 55 (65.5) |
Time from initiation to ICU admission (days) | 0 (0–1) |
Initiated before ICU admission | 41/55 (74.5) |
Cumulative dose in the ICU (mg prednisone-equivalent) | 2400 [1120–4750] |
Tocilizumab and Corticosteroids | 52 (61.9) |
Granulocyte growth factors | 59 (70.2) |
Anti-epileptic drug prophylaxis | 81 (96.4) |
Intravenous fluids, mL, median within 3 days after admission | 1000 [875-1000} b |
Vasopressors | 23 (27.4) |
Duration (days) | 2 [1–4] |
Maximum dose (µg/kg/min) | 0.3 [0.2–0.5] |
Invasive mechanical ventilation | 12 (14.3) |
Duration (days) | 4 [3–7] |
Renal replacement therapy | 4 (4.8) |
Duration (days) | 3 [1.75–8.5] |